SCHEMBL3851330

SCHEMBL3851330

CCCc1nc(-c2cnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(F)cc4F)cn23)no1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 3/20 0.39
NPC1 O15118 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
S1PR1 P21453 2/20 0.38
S1PR3 Q99500 1/20 0.38
TGFBR1 P36897 4/20 0.35
PIK3CB P42338 1/20 0.35
MTOR P42345 1/20 0.35
CDK19 Q9BWU1 1/20 0.35
CNR2 P34972 3/20 0.34
CNR1 P21554 2/20 0.34
MAPK14 Q16539 3/20 0.34
AKR1B1 P15121 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846502 0.86 PIK3CA (0.40) PIK3CAS1PR1TGFBR1PIK3CBMTOR
SCHEMBL3851333 0.86 PIK3CA (0.36) PIK3CANPC1HTTRAB9ASMN1; SMN2
SCHEMBL3849105 0.85 PIK3CA (0.39) PIK3CAS1PR1TGFBR1PIK3CBMTOR
SCHEMBL3854699 0.85 MAPK14 (0.40) PIK3CAHTTSMN1; SMN2TGFBR1PIK3CB
SCHEMBL3847144 0.81 PIK3CA (0.32) PIK3CAS1PR1TGFBR1PIK3CBMTOR
Hydrochloric Acid SCHEMBL3851015 0.81 PIK3CA (0.41) PIK3CANPC1HTTRAB9ASMN1; SMN2
SCHEMBL3847508 0.80 PIK3CA (0.46) PIK3CATGFBR1PIK3CBMTORCDK19
SCHEMBL3846856 0.80 CNR2 (0.36) PIK3CAPIK3CBMTORCDK19CNR2
SCHEMBL3847664 0.79 NPC1 (0.34) PIK3CANPC1RAB9ASMN1; SMN2S1PR1
SCHEMBL3848861 0.79 ALDH1A1 (0.36) PIK3CANPC1RAB9ASMN1; SMN2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed